BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Endosc. Dec 16, 2025; 17(12): 111614
Published online Dec 16, 2025. doi: 10.4253/wjge.v17.i12.111614
Table 1 Comparison of baseline and outcome parameters of the patients in the study group, n (%)
Variable
Total (n = 104)
Necrosectomy group (n = 36)
Non-necrosectomy group (n = 68)
P value
Demographic parameters
Age (year), mean ± SD34.93 ± 11.8138.08 ± 10.8233.26 ± 12.030.047
Gender0.258
Male792554
Female251114
Smoking20 (19.2)7 (19.4)13 (19.1)0.968
Alcohol37 (35.5)12 (33.3)25 (36.7)0.728
Comorbidity
HTN3 (2.8)1 (2.7)2 (2.9)0.717
Diabetes mellites6 (5.7)3 (8.3)3 (4.4)1.000
Etiology
Alcohol38 (36.5)12 (33.3)26 (38.2)0.788
Biliary41 (39.4)16 (44.4)25 (36.7)0.564
Traumatic1 (0.09)0 (0)1 (1.4)0.453
Idiopathic24 (23.0)8 (22.2)16 (23.5)0.788
SIRS66 (63.4)31 (86.1)35 (51.5)0.001
Acute kidney injury7 (6.7)4 (11.1)3 (4.4)0.195
Acute lung injury10 (9.6)5 (13.8)5 (7.3)0.280
ICU admission32 (30.7)15 (41.6)17 (25)0.080
Indication of metallic stent insertion
Pain98 (94.2)34 (94.4)64 (94.1)0.946
Fever51 (49.0)26 (72.2)25 (36.7)0.001
Jaundice8 (7.6)4 (11.1)4 (5.8)0.341
Vomiting10 (9.6)2 (5.5)8 (11.7)0.307
Lump5 (4.8)0 (0)5 (7.3)0.095
Time from AP to LAMS (days)49.04 ± 24.2244.64 ± 23.8951.38 ± 24.250.178
Hematological and Biochemical parameters, mean ± SD
Haemoglobin (gm/dL)10.1 ± 1.869.23 ± 1.6610.55 ± 1.810.001
Total leucocyte count/mm³14341 ± 805417372 ± 774212908 ± 78050.006
Platelets (lac/mm3)3.24 ± 1.373.30 ± 1.383.2074 ± 1.380.742
Urea (mg/dL)26.4 ± 22.530.58 ± 32.7224.19 ± 14.520.171
Creatinine (mg/dL)0.8 ± 0.50.8 ± 0.60.7 ± 0.40.635
Total Bilirubin (mg/dL)0.86 ± 1.0271.03 ± 0.7511.51 ± 0.6310.186
AST (IU/L)33.08 ± 23.839.17 ± 35.129.8 ± 14.060.580
ALT (IU/L)24.5 ± 23.3226.8 ± 3123.3 ± 180.466
ALP (IU/L)151.4 ± 94.8186.5 ± 122133 ± 700.006
Total protein (gm/dL)6.72 ± 0.96.6 ± 0.86.7 ± 1.00.572
Albumin (gm/dL)3.2 ± 0.682.9 ± 0.583.3 ± 0.60.001
Computed tomography imaging characteristics
Size of WON long axis12.17 ± 3.7613.48 ± 3.81911.38 ± 3.370.005
WON location
Head53 (50.9)23 (63.8)20 (29.4)0.001
Body99 (95.1)35 (97.2)64 (94.1)0.481
Tail76 (73.0)30 (83.3)46 (67.6)0.086
Entire26 (25)17 (47.2)9 (13.2)0.001
Amount of necrosis, mean ± SD53.98 ± 22.1171.25 ± 12.548.09 ± 21.090.001
< 30%21 (20.1)1 (2.7)20 (29.4)0.001
> 30%83 (79.8)35 (97.2)48 (70.5)
CTSI, mean ± SD8.02 ± 1.358.56 ± 1.2297.74 ± 1.3340.003
Extension of WON77 (74.0)24 (66.6)53 (77.9)0.284
Pelvic2 (1.9)1 (2.7)1 (1.4)1.000
Paracolic25 (24.0)11 (30.5)14 (20.5)0.675
Additional drainage
PCD13 (12.5)6 (16.6)7 (10.2)0.350
DPT115 (14.4)10 (27.7)5 (7.3)0.005
ENCD through LAMS6 (5.7)6 (16.6)0 (0)0.001
Outcome parameters
Clinical outcome: Success85 (81.7)25 (69.4)60 (88.2)0.022
Hospital stay duration16.87 ± 9.6421.56 ± 11.3412.68 ± 7.950.001
LAMS duration28.00 ± 10.2231.21 ± 10.4226.58 ± 9.800.033
WON recurrence in 6 months13 (12.5)8 (25)5 (7.3)0.032
Adverse events
Bleeding6 (5.7)2 (5.5)4 (5.8)0.356
Stent migration11 (10.5)7 (19.4)4 (5.8)0.136
Colonic fistula1 (0.9)0 (0)1 (1.4)0.561
6-month mortality4 (3.8)2 (5.5)2 (2.9)0.239
Table 2 Multivariate logistic regression analysis of predictors for necrosectomy
Variable
OR
95%CI lower
95%CI upper
P value
CTSI score0.7290.4161.2810.272
Amount of necrosis1.0851.0261.1480.004
< 30% or > 30% of necrosis0.3810.01310.7810.571
WON location - head1.2940.2347.1580.768
WON location - entire1.1250.1687.5120.903
Size of WON1.0950.8971.3370.371
SIRS1.5840.3048.240.585
Hemoglobin0.8150.5671.1710.269
TLC1.01.01.00.914
Albumin0.4380.1421.3480.15
Fever1.9370.5267.1270.32
Table 3 Comparison of outcomes based on timing of first direct endoscopic necrosectomy, n (%)
Outcome parameter
First DEN ≤ 7 days (n = 21)
First DEN > 7 days (n = 15)
P value
Mean number of DEN sessions1.67 ± 0.981.33 ± 0.490.244
Clinical success16 (76.1)12 (80)0.806
Hospital stay duration (days), mean ± SD22.5 ± 12.720.3 ± 9.30.288
WON recurrence within 6 months4 (19)4 (26.7)1.000
6-month mortality1 (4.8)1 (6.7)1.000